Remove 2024 Remove Disease Remove Hospital Remove Nuclear Medicine
article thumbnail

Meet the Minnies 2024 semifinal candidates

AuntMinnie

The following is the list of candidates for the 2024 edition of the Minnies, AuntMinnie.com 's campaign to recognize the best and brightest in medical imaging. This year, hundreds of candidates have been selected as semifinalists for 14 categories, ranging from Most Influential Radiology Researcher to Best New Radiology Software.

article thumbnail

Radiology suffers in missile attack on Kyiv pediatric hospital

AuntMinnie

X-ray and ultrasound machines were badly damaged in a rocket attack on Ukraine's largest children's hospital on July 8, according to radiologist Stanislav Rebenkov, MD. Rebenkov has been head of radiology at Ohmatdyt Children's Hospital since 2020. Broken glass and damaged equipment are found throughout the hospital.

Hospital 134
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CMS proposes new coverage for PET imaging agents

AuntMinnie

Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).

article thumbnail

New CMS plan adds Medicare coverage of PET imaging agents

AuntMinnie

Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).

article thumbnail

SNMMI: Y-90-FAPI-46 more effective for advanced sarcoma

AuntMinnie

An emerging radioligand therapy could be particularly effective for controlling advanced sarcoma compared to other cancers, according to research presented June 8 in a Young Investigator Award session at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting in Toronto. Image courtesy of SNMMI.

article thumbnail

The rise of theranostics: Part 2 -- Moving into communities

AuntMinnie

Thomas Hope, MD, a radiologist and nuclear medicine physician at the University of California, San Francisco (UCSF), said that approval of lutetium-177 (Lu-177) prostate-specific membrane antigen (PSMA) radioligand has driven a marked interest and excitement about theranostics and radioligand therapies (RLT). Hope added. Hope added.

article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. Traditional treatments didn't slow the disease in these patients, noted UT’s Vroman.